NCT00314366 - Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells for Therapeutic Angiogenesis (FOCUS Br) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

August 31, 2009

Study Completion Date

August 24, 2023

Conditions

Coronary Artery Disease

Interventions

BIOLOGICAL

Stem Cell Therapy

Cells are injected under electromechanical guidance and delivered by the Myostar catheter after NOGA mapping.

OTHER

Control (plasma)

Placebo patients receive an injection of plasma (control) containing 5 % albumin the the same quantity as the stem cell arm. A total of 15 injections of 0.2 ml to total 3.0 ml.

Trial Locations (1)

77030

Texas Heart Institute/Baylor St. Luke's Medical Center, Houston